S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|StemCells, Inc. Interim Results Show Improvement in Visual Function and Slowing of Disease Progression in Phase I/II Dry AMD Trial|
|StemCells, Inc. Strengthens Senior Executive Team|
|StemCells, Inc. Appoints Dr. Alan Trounson to Board of Directors|
|StemCells, Inc. Announces Closure of Enrollment in Phase I/II Dry Age-Related Macular Degeneration Trial|
|StemCells, Inc. Announces Closing of $20 Million Offering|
|StemCells, Inc. President and CEO Martin McGlynn to Present on a Regenerative Medicine Panel at the 2014 BIO International Convention|
|StemCells, Inc. Announces Proposed $20 Million Offering|
|StemCells, Inc. to Participate at the 16th Annual Rodman & Renshaw Global Investment Conference|
|StemCells, Inc. Announces Webcast to Discuss Second Quarter 2014 Financial Results|
|TCS goIT Program Inspires Students in 11 U.S. Cities on STEM Careers (2014/9/4)|
Click above to view more mutual fund data and stats for stem - StemCells Inc.